Home
Conditions
Monoclonal Gammopathy of Undetermined Significance

Clinical trial condition

Monoclonal Gammopathy of Undetermined Significance

Explore clinical trials studying Monoclonal Gammopathy of Undetermined Significance. Study availability and eligibility vary by location and protocol.

82 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Monoclonal Gammopathy of Undetermined Significance trial results

Not yet recruiting

Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging

NCT07624760

Conditions: AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +23 more
Locations: University Hospital Zurich Zurich, Canton of Zurich, Switzerland

View Trial Details

Not yet recruiting

Clonal Hematopoiesis of Immunological Significance

NCT05969821

Conditions: Autoimmune Diseases, Autoinflammatory Diseases, Blood Protein Disorders, +27 more
Locations: AP-HP, Service de médecine interne, Hôpital Saint Antoine Paris, France

View Trial Details

Not yet recruiting

Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot Study

NCT07305662

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea

View Trial Details

Not yet recruiting

Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.

NCT06489613

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies

NCT04702932

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Service de Médecine Interne Paris, France

View Trial Details

Enrolling by invitation

MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening Study

NCT06472830

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Enrolling by invitation

A Study of Carbon 13-based Deep Labelling of Bone Marrow Cells

NCT07057583

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Active, not recruiting

Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program

NCT05831358

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Active, not recruiting

Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy

NCT05939037

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: University Medical Center Utrecht Utrecht, Netherlands

View Trial Details

Active, not recruiting

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

NCT04850846

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Dana-Farber at Brighton Brighton, Massachusetts, United States

Dana-Farber at Merrimack Valley Methuen, Massachusetts, United States

View Trial Details

Monoclonal Gammopathy of Undetermined Significance

Monoclonal Gammopathy of Undetermined Significance trial results

Related conditions